Freenome

Freenome

  • Founded in 2014
  • 201-500 Employees
  • $290M Corporate Round on 2022-01

Careers at Freenome


About Freenome

Freenome is a company focused on advancing early cancer detection through the integration of scientific innovation and artificial intelligence. Their platform uses multiomics technology to identify cancer at its most treatable stages, enabling early intervention. The company emphasizes a standard blood draw method for ease of use, aiming to redefine cancer screening. Freenome is driven by a robust clinical research program and is committed to discovering, developing, and validating early cancer detection tests, employing a multidisciplinary team dedicated to pushing the boundaries of what's possible in cancer diagnostics.